Related Experiment Videos

Ovarian ablation as adjuvant therapy for breast cancer

¹The Johns Hopkins Comprehensive Cancer Center, 1650 Orleans St., Rm. 409, Baltimore, MD 21231, USA. davidna@jhmi.edu

Journal of the National Cancer Institute. Monographs

|January 5, 2002

Abstract

No abstract available in PubMed .

Related Concept Videos

Articles linked to this work by shared authors, journal, and citation graph.

Final outcomes of the SOFT and TEXT phase III trials in premenopausal hormone receptor-positive early breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2026

Genomic characterisation of hormone receptor-positive breast cancer arising in very young women.

Annals of oncology : official journal of the European Society for Medical Oncology·2023

Refined estimates of local recurrence risks by DCIS score adjusting for clinicopathological features: a combined analysis of ECOG-ACRIN E5194 and Ontario DCIS cohort studies.

Breast cancer research and treatment·2018

Recurrent hyperactive ESR1 fusion proteins in endocrine therapy-resistant breast cancer.

Annals of oncology : official journal of the European Society for Medical Oncology·2018

Functional interaction of histone deacetylase 5 (HDAC5) and lysine-specific demethylase 1 (LSD1) promotes breast cancer progression.

Oncogene·2016

Stress hormones reduce the efficacy of paclitaxel in triple negative breast cancer through induction of DNA damage.

British journal of cancer·2015

See all related articles